During this session, the panelists discussed investment strategies in the Contract Development and Manufacturing Organization (CDMO) space, emphasizing factors like supply and demand dynamics, quality control, and the impact of the BIOSECURE Act on manufacturing trends.
Read the full article: Key Takeaways | Pharma and Medtech Manufacturing and Contract Development //
Source: https://www.mwe.com/insights/key-takeaways-pharma-and-medtech-manufacturing-and-contract-development/